within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AA07_Acenocoumarol;

model Acenocoumarol
  extends Pharmacolibrary.Drugs.ATC.B.B01AA07;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>B01AA07</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Acenocoumarol is a vitamin K antagonist oral anticoagulant, structurally related to warfarin, used for the prevention and treatment of thromboembolic disorders such as deep vein thrombosis, pulmonary embolism, and for stroke prevention in atrial fibrillation. It is approved and used in several countries, though not in the United States.</p><h4>Pharmacokinetics</h4><p>Reported pharmacokinetic parameters in healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>Trailokya, A, et al., &amp; Tiwaskar, M (2016). Acenocoumarol: A Review of Anticoagulant Efficacy and Safety. <i>The Journal of the Association of Physicians of India</i> 64(2) 88–93. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27730796/\">https://pubmed.ncbi.nlm.nih.gov/27730796</a></p></li><li><p>Sunkara, G, et al., &amp; Ligueros-Saylan, M (2004). The effect of nateglinide on the pharmacokinetics and pharmacodynamics of acenocoumarol. <i>Current medical research and opinion</i> 20(1) 41–48. DOI:<a href=\"https://doi.org/10.1185/030079903125002685\">10.1185/030079903125002685</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/14741071/\">https://pubmed.ncbi.nlm.nih.gov/14741071</a></p></li><li><p>Thijssen, HH, &amp; Ritzen, B (2003). Acenocoumarol pharmacokinetics in relation to cytochrome P450 2C9 genotype. <i>Clinical pharmacology and therapeutics</i> 74(1) 61–68. DOI:<a href=\"https://doi.org/10.1016/S0009-9236(03)00088-2\">10.1016/S0009-9236(03)00088-2</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12844136/\">https://pubmed.ncbi.nlm.nih.gov/12844136</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Acenocoumarol;
